Bone Health in Cancer
Digital Collections | First published: 22 June 2021 | Last updated: 3 November 2021
Guest Editor: Lorenz C. Hofbauer
Special Section: Cancer and Bone
Disruption of Jmjd3/p16Ink4a Signaling Pathway Causes Bizarre Parosteal Osteochondromatous Proliferation (BPOP)-like Lesion in Mice
Feng Zhang et al.
Journal of Bone and Mineral Research
First Published: 25 June 2021
A functional three-dimensional microphysiological human model of myeloma bone disease
Richard J. Visconti et al.
Journal of Bone and Mineral Research
First Published: 25 June 2021
Genome-wide Association Studies Reveal Novel Locus With Sex-/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors
Cindy Im et al.
Journal of Bone and Mineral Research
First Published: 18 December 2020
Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer
Huifang Lu et al.
Journal of Bone and Mineral Research
First Published: 23 January 2021
Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial
Ada S Cheung et al.
Journal of Bone and Mineral Research
First Published: 16 June 2020
Individualized Bone-Protective Management in Long-Term Cancer Survivors With Bone Metastases
Tilman D Rachner et al.
Journal of Bone and Mineral Research
First Published: 16 June 2021
Performance of FRAX in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study
William D Leslie et al.
Journal of Bone and Mineral Research
First Published: 09 May 2019
